Illumina, Inc. (ILMN) Financials
ILMN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 10.0 billion | 4.3 billion |
2023-12-31 | 10.1 billion | 4.4 billion |
2023-09-30 | 10.1 billion | 4.2 billion |
2023-06-30 | 11.8 billion | 5.2 billion |
ILMN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 41.0 million | 96.0 million |
2023-12-31 | 172.0 million | 94.0 million |
2023-09-30 | 94.0 million | 87.0 million |
2023-06-30 | 58.0 million | 106.0 million |
ILMN Net Income
No data available :(
ILMN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 1.1 billion | - | 786.0 million |
2023-12-31 | 1.1 billion | - | 773.0 million |
2023-09-30 | 933.0 million | 1.5 billion | 698.0 million |
2023-06-30 | 1.6 billion | 1.5 billion | 726.0 million |
ILMN Shares Outstanding
ILMN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 36.0 million | 338.0 million | 439.0 million | - |
2023-12-31 | 51.0 million | 329.0 million | 485.0 million | - |
2023-09-30 | 45.0 million | 315.0 million | 303.0 million | - |
2023-06-30 | 47.0 million | 358.0 million | 450.0 million | - |
ILMN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 1.1 billion | 409.0 million |
2023-12-31 | 1.1 billion | 447.0 million |
2023-09-30 | 1.1 billion | 435.0 million |
2023-06-30 | 1.2 billion | 444.0 million |
ILMN
Price: $111.07
52 week price:
Payout Ratio Range:
Earnings Per Share: -8.15 USD
P/E Ratio: -20.31
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.1 million
Ebitda: 273.0 millionMarket Capitalization: 17.6 billion